15-49424487-A-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_002009.4(FGF7):​c.190A>G​(p.Ile64Val) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

FGF7
NM_002009.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.09

Publications

0 publications found
Variant links:
Genes affected
FGF7 (HGNC:3685): (fibroblast growth factor 7) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein is a potent epithelial cell-specific growth factor, whose mitogenic activity is predominantly exhibited in keratinocytes but not in fibroblasts and endothelial cells. Studies of mouse and rat homologs of this gene implicated roles in morphogenesis of epithelium, reepithelialization of wounds, hair development and early lung organogenesis. [provided by RefSeq, Jul 2008]
FAM227B (HGNC:26543): (family with sequence similarity 227 member B)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.057400435).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGF7NM_002009.4 linkc.190A>G p.Ile64Val missense_variant Exon 2 of 4 ENST00000267843.9 NP_002000.1 P21781-1A0A7U3JVY2
FAM227BNM_152647.3 linkc.1013-53088T>C intron_variant Intron 11 of 15 ENST00000299338.11 NP_689860.2 Q96M60-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGF7ENST00000267843.9 linkc.190A>G p.Ile64Val missense_variant Exon 2 of 4 1 NM_002009.4 ENSP00000267843.4 P21781-1
FAM227BENST00000299338.11 linkc.1013-53088T>C intron_variant Intron 11 of 15 2 NM_152647.3 ENSP00000299338.6 Q96M60-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461386
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
727006
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33436
American (AMR)
AF:
0.00
AC:
0
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86232
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
9.00e-7
AC:
1
AN:
1111666
Other (OTH)
AF:
0.00
AC:
0
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 30, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.190A>G (p.I64V) alteration is located in exon 2 (coding exon 1) of the FGF7 gene. This alteration results from a A to G substitution at nucleotide position 190, causing the isoleucine (I) at amino acid position 64 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
17
DANN
Benign
0.80
DEOGEN2
Benign
0.34
T;T;.;.
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.074
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.78
.;T;T;T
M_CAP
Benign
0.0020
T
MetaRNN
Benign
0.057
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-2.0
N;N;N;.
PhyloP100
6.1
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
0.17
N;.;N;N
REVEL
Benign
0.10
Sift
Benign
1.0
T;.;T;T
Sift4G
Benign
1.0
T;T;T;T
Polyphen
0.0
B;B;.;.
Vest4
0.034
MutPred
0.34
Gain of MoRF binding (P = 0.1148);Gain of MoRF binding (P = 0.1148);Gain of MoRF binding (P = 0.1148);.;
MVP
0.44
MPC
0.72
ClinPred
0.53
D
GERP RS
3.4
Varity_R
0.039
gMVP
0.31
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr15-49716684; API